Key points:
·Sweden has the lowest smoking rate in Europe and the lowest lung cancer mortality rate in the EU.
·Smokeless nicotine products help reduce smoking rates in the country.
·Sweden plans to become the world's first smoke-free country.
【2Firsts News Flash】According to Euro Weekly News on August 4th, Sweden is leading a smoke-free revolution in Europe, becoming the country with the lowest smoking rates. At the same time, Sweden has the lowest lung cancer death rate in the EU, with this trend continuing to decline, especially among elderly men and in densely populated cities.
Sweden has achieved such success in tobacco control thanks to the country's increased accessibility to nicotine products with lower harm compared to cigarettes, rather than comprehensive restrictions on nicotine and tobacco products. These products mainly include smokeless tobacco products like Snus, nicotine pouches, and e-cigarettes, which are not only widely accepted in society but also more affordable than traditional cigarettes. More importantly, these products greatly reduce the risk of secondhand smoke, creating a safer environment for non-smokers.
Snus is one of the most popular smokeless tobacco products in Sweden. This small, smokeless product is placed between the gums and lips, and has been a major factor in reducing the number of smokers in the country, especially among Swedish men. In addition, nicotine pouches and e-cigarettes are also widely used and have gained public acceptance as tools to help nicotine addicts quit smoking. The Swedish government is actively promoting these products as alternatives to traditional cigarettes, while also controlling the consumption of tobacco and related legislation in the country.
Currently, Sweden is on track to become the world's first smoke-free country, leading other EU countries by 17 years. Data shows that only about 5% of adults in Sweden smoke daily. According to the World Health Organization's standards, a country must have a daily smoking rate of less than 5% among adults nationwide to be officially declared "smoke-free.
However, despite the decrease in smoking rates, nicotine addiction has not disappeared. For example, overuse of e-cigarettes may lead to serious health consequences, although as a relatively new product, there is currently a lack of long-term evidence on its health effects. In addition, e-cigarettes are associated with a lung disease called bronchiolitis obliterans, and the widely popular Snus products may also have negative health effects, although they do not directly cause lung cancer, but are known to increase the risk of esophageal cancer, pancreatic cancer, stomach cancer, colorectal cancer, cardiovascular disease, and stroke.
In the case of nicotine products, the ideal situation is for the public to understand all potential health risks they may cause, especially with long-term daily consumption. In Sweden, they have chosen the lesser evil approach and are moving towards a smoke-free direction.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
